UBIO
Proshares UltraPro NASDAQ Biotechnology
UBIO
UBIO
Delisted
UBIO was delisted on the 27th of March, 2020.
7 hedge funds and large institutions have $3.18M invested in Proshares UltraPro NASDAQ Biotechnology in 2016 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
Holders
7
Holding in Top 10
–
Calls
$1.04M
Puts
$834K
Top Buyers
| 1 | +$808K | |
| 2 | +$755K | |
| 3 | +$330K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$253K |
| 5 |
Morgan Stanley
New York
|
+$15K |
Top Sellers
| 1 | -$810K | |
| 2 | -$126K | |
| 3 | -$58.1K | |
| 4 |
Creative Planning
Overland Park,
Kansas
|
-$5K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$2K |